Sign In
test

Teresa Isele

Rhenman & Partners Asset Management Ab

Assets Managed
$810.49M
Holdings
86
Last Quarter
2026 - Q1
Filed Date
1mo 13d ago
Growth Rate
-24.25%(2Q avg: -2.92%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Rhenman & Partners Asset Management Ab's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 86 positions.

Assets under management

The assets under management (AUM) of Rhenman & Partners Asset Management Ab over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 810.49M in assets, with a quarterly growth rate of -24.25% and a 2-quarter average growth rate of -2.92%. The portfolio is managed by Teresa Isele, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
BSX
Boston Scientific Corp
Recent Activity
Increased 44.95%
4.84%
$39.219M
625,000 shares@ $62.75 avg price
REGN
Regeneron Pharmaceuticals
Recent Activity
Decreased -21.66%
4.59%
$37.164M
48,100 shares@ $772.64 avg price
LLY
Eli Lilly & Co
Recent Activity
Decreased -20.14%
3.83%
$31.01M
33,715 shares@ $919.78 avg price
INSM
Insmed Inc
Recent Activity
Increased 40.66%
3.23%
$26.124M
159,760 shares@ $163.52 avg price
CVS
Cvs Health Corp
Recent Activity
Increased 0.3%
2.99%
$24.167M
336,500 shares@ $71.82 avg price
GILD
Gilead Sciences Inc
Recent Activity
Increased 32.98%
2.89%
$23.379M
167,750 shares@ $139.38 avg price
TMO
Thermo Fisher Scientific Inc
Recent Activity
Increased 22.89%
2.51%
$20.32M
41,340 shares@ $491.53 avg price
BIIB
Biogen Inc
Recent Activity
Increased 18.14%
2.47%
$20.001M
109,100 shares@ $183.33 avg price
VRTX
Vertex Pharmaceuticals Inc
Recent Activity
Increased 26.95%
2.4%
$19.418M
43,485 shares@ $446.55 avg price
ALHC
Alignment Healthcare Inc
Recent Activity
Increased 4.36%
2.3%
$18.562M
1.053M shares@ $17.62 avg price

1-10 of 86